Ranier's Triple P Injection Recall: Risk of Contaminated Sterile Products
Ranier's Compounding Laboratory recalls Triple P (Prostaglandin/Papaverine/Phentolamine) injections due to potential lack of sterility. This affects specific vial sizes and lot numbers. Consumers should contact the lab for details.
Recall notice
Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.
Contact the company
What happened, in plain English
Ranier's Compounding Laboratory is recalling Triple P injections (0.008/22.5/0.83 mg/mL) in 5mL and 10mL vials because their manufacturing practices may have compromised sterility. This poses a risk of infection if the product is used without proper sterilization. Read more at govinfonow.com/recall/39846-ranier-s-triple-p-injection-recall-risk-of-contaminated-sterile.
Source Summary by GovInfoNow · govinfonow.com/recall/39846-ranier-s-triple-p-injection-recall-risk-of-contaminated-sterile · Updated October 6, 2026 · FDA enforcement record: FDA #D-1083-2018
Cite this page
“Ranier's Triple P Injection Recall: Risk of Contaminated Sterile Products.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39846-ranier-s-triple-p-injection-recall-risk-of-contaminated-sterile. Based on FDA recall #D-1083-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1083-2018%22&limit=1).
Why it’s dangerous
The recall states that manufacturing practices at the lab may have failed to ensure the products are sterile. Since these injections are intended for medical use, contamination could lead to infections or other health issues if used improperly.
Who’s affected
Prescription users of Triple P injections for medical purposes. Patients receiving this medication from Ranier's Compounding Laboratory are most at risk.
How to tell if you have this one
Check for Triple P injections (Prostaglandin/Papaverine/Phentolamine) in 5mL or 10mL vials labeled as Rx only from Ranier's Compounding Laboratory in Jeannette, PA.
- Brand
Ranier's- Category
Drug
All 15 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Product was distributed within the state of Pennsylvania.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1080-2018 | Atropine 0.01% Opth Solution, 5 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 5 droptainers |
| D-1081-2018 | DMSO 6.25% Opth Sol, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 1 droptainer |
| D-1082-2018 | Avastin 1.25 mg/0.05 mL prefilled syringe, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 213 prefilled syringes |
| D-1083-2018 | Triple P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.008/22.5/0.83 mg/mL, packaged in a) 5 mL and b) 10 mL vials, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | a) 1 vial; b) 1 vial |
| D-1084-2018 | PR/PA/PH (Prostaglandin/Papaverine/Phentolamine) Injection, 10mcg/30/1mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 1 vial |
| D-1085-2018 | Morphine Sulf inhalation, 5mg/3cc, 3cc per vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 60 vials |
| D-1086-2018 | Dehydrated Alcohol Solution, packaged in a) 1 mL and b) 3 mL vials, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | a) 2 vials; b) 1 vial |
| D-1087-2018 | Vitamin D3 Injection, 50,000 IU/mL, 4 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 2 vials |
| D-1088-2018 | Medroxprogesterone 1% Ophthalmic Solution, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 1 droptainer |
| D-1089-2018 | Acetylcysteine 10% Oph Solution, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots with expiry | 1 droptainer |
| D-1090-2018 | P/P/P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.02/30/2 mg/mL, 5 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 2 vials |
| D-1091-2018 | PRASH 12.2mcg/1.22m/19.29 (Prostaglandin/Phentolamine/Papaverine) Injection, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 1 vial |
| D-1092-2018 | PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Injection, 18mcg/1.8 mg/0.2 mg/0.02 mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 1 vial |
| D-1093-2018 | P/P/P 0.02/40/2mg/mL(Prostaglandin//Papaverine/Phentolamine) Injection, 0.02/40/2 mg/mL, 1 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 1 vial |
| D-1094-2018 | Papav 300/Phent 5mg/10mL (Papaverine/Phentolamine) Injection,300 mg/5 mg/10 mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.; All lots within expiry | 2 vials |
What to do — step by step
Contact Lab for Details
Reach out to Ranier's Compounding Laboratory at 1107 Lowry Avenue Suite A, Jeannette, PA 15644 for specific lot numbers and instructions.
Where it went and when
Where it was distributed
Distributed in Pennsylvania.
FDA distribution: “Product was distributed within the state of Pennsylvania.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Pennsylvania.
Recall timeline
FDA terminated this recall 4.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1083-2018 (July 25, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1083-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.